Evidence about the use of glucocorticoids as therapy for sepsis: an integrative literature review
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/26196 |
Resumo: | Introduction: sepsis is a systemic inflammatory disease associated with an infection with severe manifestations that occurs throughout the body. However, this infection does not necessarily have to be everywhere in the body, it can be restricted to just one place, but cause an inflammatory response throughout the body to try to control the cause of the infection. Objective: to demonstrate the current evidence on the use of corticosteroids in the treatment of sepsis in patients hospitalized in intensive care units (ICUs). Methodology: this is a descriptive research of the integrative literature review type. The descriptors were crossed, in English: "sepsis", "hemodynamic", "corticosteroids" in Portuguese: "sepsis", "hemodynamics", "corticosteroids" and in Spanish: "sepsis", "hemodynamic", "corticosteroids", in the following databases: National Library of Medicine (PubMed MEDLINE), Scientific Electronic Library Online (Scielo), Cochrane Database of Systematic Reviews (CDSR), Google Scholar, Virtual Health Library (BVS) and EBSCO Information Services. Results and discussion: treatment can be done with corticosteroids in order to attenuate and modify the inflammatory response, in addition to offering an affordable cost. However, some side effects and adequate forms of administration corroborate the fact that there are some controversies regarding the use of corticosteroids, such as hydrocortisone, for the treatment of patients with sepsis, even with satisfactory results. Final considerations: corticosteroids, especially hydrocortisone, can be used to treat patients with sepsis. According to the literature used, the results are satisfactory and costing is easy to adhere to. However, the use of these drugs, even with benefits, is still controversial, due to the side effects caused, the dosage and the form of administration. Thus, discussions on this subject exist. |
id |
UNIFEI_916b62f21995f9669bee9516d315741d |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/26196 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Evidence about the use of glucocorticoids as therapy for sepsis: an integrative literature reviewEvidencia sobre el uso de glucocorticoides como terapia para la sepsis: una revisión integrativa de la literaturaEvidências acerca do uso de glicocorticoides como terapêutica para sepse: uma revisão integrativa de literaturaGlucocorticoidesSepticemiaTerapia intensiva.GlucocorticoidsSepsisIntensive therapy.GlicocorticoidesSepseTerapia intensiva. Introduction: sepsis is a systemic inflammatory disease associated with an infection with severe manifestations that occurs throughout the body. However, this infection does not necessarily have to be everywhere in the body, it can be restricted to just one place, but cause an inflammatory response throughout the body to try to control the cause of the infection. Objective: to demonstrate the current evidence on the use of corticosteroids in the treatment of sepsis in patients hospitalized in intensive care units (ICUs). Methodology: this is a descriptive research of the integrative literature review type. The descriptors were crossed, in English: "sepsis", "hemodynamic", "corticosteroids" in Portuguese: "sepsis", "hemodynamics", "corticosteroids" and in Spanish: "sepsis", "hemodynamic", "corticosteroids", in the following databases: National Library of Medicine (PubMed MEDLINE), Scientific Electronic Library Online (Scielo), Cochrane Database of Systematic Reviews (CDSR), Google Scholar, Virtual Health Library (BVS) and EBSCO Information Services. Results and discussion: treatment can be done with corticosteroids in order to attenuate and modify the inflammatory response, in addition to offering an affordable cost. However, some side effects and adequate forms of administration corroborate the fact that there are some controversies regarding the use of corticosteroids, such as hydrocortisone, for the treatment of patients with sepsis, even with satisfactory results. Final considerations: corticosteroids, especially hydrocortisone, can be used to treat patients with sepsis. According to the literature used, the results are satisfactory and costing is easy to adhere to. However, the use of these drugs, even with benefits, is still controversial, due to the side effects caused, the dosage and the form of administration. Thus, discussions on this subject exist.Introducción: la sepsis es una enfermedad inflamatoria sistémica asociada a una infección con manifestaciones graves que se presenta en todo el organismo. Sin embargo, esta infección no necesariamente tiene que estar en todas partes del cuerpo, puede estar restringida a un solo lugar, pero causar una respuesta inflamatoria en todo el cuerpo para tratar de controlar la causa de la infección. Objetivo: demostrar la evidencia actual sobre el uso de corticoides en el tratamiento de la sepsis en pacientes hospitalizados en unidades de cuidados intensivos (UCI). Metodología: se trata de una investigación descriptiva del tipo revisión integrativa de la literatura. Se cruzaron los descriptores, en inglés: "sepsis", "hemodynamic", "corticosteroids", en portugués: "sepsis", "hemodynamics", "corticosteroids" y en español: "sepsis", "hemodynamic", "corticosteroids", en las siguientes bases de datos: National Library of Medicine (PubMed MEDLINE), Scientific Electronic Library Online (Scielo), Cochrane Database of Systematic Reviews (CDSR), Google Scholar, Virtual Health Library (BVS) y EBSCO Information Services. Resultados y discusión: el tratamiento puede realizarse con corticoides para atenuar y modificar la respuesta inflamatoria, además de ofrecer un costo accesible. Sin embargo, algunos efectos secundarios y formas de administración adecuadas corroboran el hecho de que existen algunas controversias en cuanto al uso de corticoides, como la hidrocortisona, para el tratamiento de pacientes con sepsis, incluso con resultados satisfactorios. Consideraciones finales: los corticosteroides, especialmente la hidrocortisona, pueden usarse para tratar pacientes con sepsis. De acuerdo con la literatura utilizada, los resultados son satisfactorios y el costeo es fácil de cumplir. Sin embargo, el uso de estos fármacos, aun con beneficios, sigue siendo controvertido, debido a los efectos secundarios que provocan, la posología y la forma de administración. Por lo tanto, existen discusiones sobre este tema.Introdução: a sepse consiste em uma doença inflamatória sistêmica associada a uma infecção com manifestações graves que ocorre por todo o organismo. No entanto, essa infecção não precisa estar necessariamente em todos os locais do organismo, pode estar restrita em apenas um local, mas causar uma resposta inflamatória por todo o corpo para tentar controlar a causa da infecção. Objetivo: demonstrar as atuais evidências sobre o uso de corticosteroides no tratamento da sepse em paciente hospitalizados nas unidades de terapia intensiva (UTI’s). Metodologia: trata-se de uma pesquisa descritiva do tipo revisão integrativa da literatura. Foi realizado o cruzamento dos descritores, em inglês: "sepsis", "hemodynamic", "corticosteroids" em português: "sepse", "hemodinâmica", "corticosteroides" e em espanhol: "sepsis", "hemodinámico", "corticosteroides", nas seguintes bases de dados: National Library of Medicine (PubMed MEDLINE), Scientific Electronic Library Online (Scielo), Cochrane Database of Systematic Reviews (CDSR), Google Scholar, Biblioteca Virtual em Saúde (BVS) e EBSCO Information Services. Resultados e discussão: o tratamento pode ser feito com corticosteroides a fim de atenuar e modificar a resposta inflamatória, além de oferecerem um custo acessível. Porém, alguns efeitos colaterais e as formas adequadas de administração corroboram para que haja algumas controvérsias quanto ao uso dos corticoides, como a hidrocortisona, para tratamento de pacientes com sepse, mesmo com resultados satisfatórios. Considerações finais: os corticoides, em especial a hidrocortisona, podem ser utilizados para o tratamento dos pacientes com sepse. Conforme as literaturas utilizadas, os resultados são satisfatórios e possuem um custeio de fácil adesão. Contudo, o uso destes medicamentos, mesmo apresentando benefícios, ainda é controverso, devido aos efeitos colaterais causados, à posologia e à forma de administração. Desta forma, discussões acerca deste assunto existem.Research, Society and Development2022-02-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/2619610.33448/rsd-v11i2.26196Research, Society and Development; Vol. 11 No. 2; e59211226196Research, Society and Development; Vol. 11 Núm. 2; e59211226196Research, Society and Development; v. 11 n. 2; e592112261962525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/26196/22891Copyright (c) 2022 Melina Fonseca Maia França Coury Alves; Bárbara Queiroz de Figueiredo; Bruno Faria Coury; Flávia Garcia Freitas; Julia da Cunha Ribeiro; Júlia de Sousa Oliveira; Júlia Silva Coimbra Costa; Juliana Silva Neiva; Rúbia Carla Oliveirahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessAlves, Melina Fonseca Maia França Coury Figueiredo, Bárbara Queiroz deCoury, Bruno FariaFreitas, Flávia GarciaRibeiro, Julia da CunhaOliveira, Júlia de SousaCosta, Júlia Silva CoimbraNeiva, Juliana SilvaOliveira, Rúbia Carla2022-02-07T01:42:50Zoai:ojs.pkp.sfu.ca:article/26196Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:44:17.826291Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Evidence about the use of glucocorticoids as therapy for sepsis: an integrative literature review Evidencia sobre el uso de glucocorticoides como terapia para la sepsis: una revisión integrativa de la literatura Evidências acerca do uso de glicocorticoides como terapêutica para sepse: uma revisão integrativa de literatura |
title |
Evidence about the use of glucocorticoids as therapy for sepsis: an integrative literature review |
spellingShingle |
Evidence about the use of glucocorticoids as therapy for sepsis: an integrative literature review Alves, Melina Fonseca Maia França Coury Glucocorticoides Septicemia Terapia intensiva. Glucocorticoids Sepsis Intensive therapy. Glicocorticoides Sepse Terapia intensiva. |
title_short |
Evidence about the use of glucocorticoids as therapy for sepsis: an integrative literature review |
title_full |
Evidence about the use of glucocorticoids as therapy for sepsis: an integrative literature review |
title_fullStr |
Evidence about the use of glucocorticoids as therapy for sepsis: an integrative literature review |
title_full_unstemmed |
Evidence about the use of glucocorticoids as therapy for sepsis: an integrative literature review |
title_sort |
Evidence about the use of glucocorticoids as therapy for sepsis: an integrative literature review |
author |
Alves, Melina Fonseca Maia França Coury |
author_facet |
Alves, Melina Fonseca Maia França Coury Figueiredo, Bárbara Queiroz de Coury, Bruno Faria Freitas, Flávia Garcia Ribeiro, Julia da Cunha Oliveira, Júlia de Sousa Costa, Júlia Silva Coimbra Neiva, Juliana Silva Oliveira, Rúbia Carla |
author_role |
author |
author2 |
Figueiredo, Bárbara Queiroz de Coury, Bruno Faria Freitas, Flávia Garcia Ribeiro, Julia da Cunha Oliveira, Júlia de Sousa Costa, Júlia Silva Coimbra Neiva, Juliana Silva Oliveira, Rúbia Carla |
author2_role |
author author author author author author author author |
dc.contributor.author.fl_str_mv |
Alves, Melina Fonseca Maia França Coury Figueiredo, Bárbara Queiroz de Coury, Bruno Faria Freitas, Flávia Garcia Ribeiro, Julia da Cunha Oliveira, Júlia de Sousa Costa, Júlia Silva Coimbra Neiva, Juliana Silva Oliveira, Rúbia Carla |
dc.subject.por.fl_str_mv |
Glucocorticoides Septicemia Terapia intensiva. Glucocorticoids Sepsis Intensive therapy. Glicocorticoides Sepse Terapia intensiva. |
topic |
Glucocorticoides Septicemia Terapia intensiva. Glucocorticoids Sepsis Intensive therapy. Glicocorticoides Sepse Terapia intensiva. |
description |
Introduction: sepsis is a systemic inflammatory disease associated with an infection with severe manifestations that occurs throughout the body. However, this infection does not necessarily have to be everywhere in the body, it can be restricted to just one place, but cause an inflammatory response throughout the body to try to control the cause of the infection. Objective: to demonstrate the current evidence on the use of corticosteroids in the treatment of sepsis in patients hospitalized in intensive care units (ICUs). Methodology: this is a descriptive research of the integrative literature review type. The descriptors were crossed, in English: "sepsis", "hemodynamic", "corticosteroids" in Portuguese: "sepsis", "hemodynamics", "corticosteroids" and in Spanish: "sepsis", "hemodynamic", "corticosteroids", in the following databases: National Library of Medicine (PubMed MEDLINE), Scientific Electronic Library Online (Scielo), Cochrane Database of Systematic Reviews (CDSR), Google Scholar, Virtual Health Library (BVS) and EBSCO Information Services. Results and discussion: treatment can be done with corticosteroids in order to attenuate and modify the inflammatory response, in addition to offering an affordable cost. However, some side effects and adequate forms of administration corroborate the fact that there are some controversies regarding the use of corticosteroids, such as hydrocortisone, for the treatment of patients with sepsis, even with satisfactory results. Final considerations: corticosteroids, especially hydrocortisone, can be used to treat patients with sepsis. According to the literature used, the results are satisfactory and costing is easy to adhere to. However, the use of these drugs, even with benefits, is still controversial, due to the side effects caused, the dosage and the form of administration. Thus, discussions on this subject exist. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-02-06 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/26196 10.33448/rsd-v11i2.26196 |
url |
https://rsdjournal.org/index.php/rsd/article/view/26196 |
identifier_str_mv |
10.33448/rsd-v11i2.26196 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/26196/22891 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 11 No. 2; e59211226196 Research, Society and Development; Vol. 11 Núm. 2; e59211226196 Research, Society and Development; v. 11 n. 2; e59211226196 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052762692780032 |